Effect of diphenylhydantoin sodium polybutylcyanoacrylate nanoparticles on rat models of epilepsy
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF NEUROMEDICINE
- Issue:
- 4
- DOI:
- 10.3760/cma.j.issn.1671-8925.2011.04.002
- Key Word:
- 癫痫;纳米微粒;苯妥英钠;聚氰基丙烯酸正丁酯;Epilepsy;Nanoparticle;Diphenylhydantoin sodium;Poly n-butyl cyanoacrylate
Abstract： Objective To evaluate the effects of diphenylhydantoin sodiumpolybutylcyanoacrylate nanoparticles (DPH-PBCA-NPs) and DPH-PBCA-NPs modified with Tween-80on rat models of epilepsy, and investigate the advantage of nanoparticle as the drug delivery system.Methods The rat models of acute epilepsy induced by lithium pilocarpine were established and randomly divided into 5 groups: group Ⅰ (performing injection of DPH-PBCA-NPs modified with Tween-80), group Ⅱ (performing injection of DPH-PBCA-NPs), group Ⅲ (performing injection of diphenylhydantoin sodium), group Ⅳ (performing injection of PBCA-NPs) and group Ⅴ (performing injection of physiological saline). The changes of electroencephalogram (EEG) manifestations of these rats were observed by using video-EEG monitoring; and their behavioral changes were noted too.Results The lithium pilocarpine induced rat models of acute epilepsy were successfully established and their status epilepticus were confirmed by EEG and their behaviors. The effective rate of DPH-PBCA-NPs modified with Tween-80 and DPH-PBCA-NPs was 91.67% and 54.55%, respectively;the effective rate of rats in group Ⅲ was 50%, and the effective rate of rats in group Ⅳ and Ⅴ was 0%;DPH-PBCA-NPs modified with Tween-80 enjoyed a better effect than DPH-PBCA-NPs and DPH (P＜0.05). Conclusion DPH-PBCA-NPs and DPH-PBCA-NPs modified with Tween-80 can be used to improve the behaviors of rats with acute epilepsy and modify the results of EEG of these rats.Nanoparticles as drug delivery system can help the drugs having their effects much quickly and effectively.
- [1]卢剑,常津,赵硕,等.载药纳米微粒表面性能与表面改性[J].2003,(1).
- [2]王文志,吴建中,王德生,等.中国五省农村人群癫痫流行病学抽样调查[J].2002,(7).
- [3]Kaplan PW.The EEG of status epilepticus.[J].2006,23(3).
- [4]Robert S. Fisher,Jet Ho.Potential New Methods for Antiepileptic Drug Delivery[J].2002,16(9).
- [5]Brenner RP,Mendez OE.Increasing the yield of EEG.[J].2006,23(4).
- [6]Lin S,Das D.Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration.[J].2005,94(6).
- [7]Minicucci F,Bellini A,Paleari C,etc.Status epilepticus.[J].2006,27(Suppl.1).
- [8]Klitgaard H,Matagne A,Vanneste Goemaere J,etc.Pilocarpine-induced epileptogenesis in the rat: Impact of initial duration of status epilepticus on electrophysiological and neuropathological alterations.[J].2002,51(1).
- [9]Sills GJ,Brodie MJ,Kwan P.The mechanisms of action of commonly used antiepileptic drugs.[J].2001,90(1).
- [10]Scherrmann JM.Drug delivery to brain via the blood-brain barrier.[J].2002,38(6).
- [11]Ghougassian DF,Cook MJ,D'Souza W,etc.Evaluating the Utility of Inpatient Video-EEG Monitoring.[J].2004,45(8).
- [12]O K, Steinlein,J L, Noebels.Ion channels and epilepsy in man and mouse.[J].2000,10(3).
- [13]Betting LE,Mory SB,Lopes Cendes I,etc.EEG features in idiopathic generalized epilepsy: clues to diagnosis.[J].2006,47(3).
- [14]Esmaeil N,Maren S,Macdonald R,etc.Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus.[J].2002,50(3).
- [15]Kreuter J,Khalansky AS,Ambruosi A,etc.Biodistribution of polysorbate 80-coated doxorubicin-loaded (14C)-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats.[J].2006,14(2).
- [16]Mario, Tudor,Lorainne, Tudor,Katarina Ivana, Tudor.[Hans Berger (1873-1941)--the history of electroencephalography].[J].2005,59(4).